{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:56:31Z","timestamp":1790942191761,"version":"4.1.0"},"reference-count":42,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Endovascular treatment of femoropopliteal atherosclerotic disease has evolved from plain balloon angioplasty and routine stenting toward lesion-oriented strategies that combine plaque assessment, selective vessel preparation, antiproliferative drug delivery, and provisional scaffolding. The increasing availability of drug-coated balloons, drug-eluting stents, atherectomy, intravascular lithotripsy, intravascular imaging, and sirolimus-based technologies has improved therapeutic options but has also made device selection more complex. Objective: To synthesize comparative evidence and present a practical lesion-oriented framework for selecting vessel preparation, antiproliferative therapy, and selective scaffolding. Methods: A structured narrative review of contemporary evidence was performed, prioritizing randomized controlled trials, head-to-head comparisons, systematic reviews, meta-analyses, and consensus documents relevant to femoropopliteal intervention. Results: Lesion morphology\u2014particularly length, chronic total occlusion, calcification pattern, popliteal involvement, and in-stent restenosis\u2014strongly influences procedural strategy and durability. Atherectomy and specialty balloons can optimize acute vessel preparation in selected lesions, although consistent long-term superiority has not been demonstrated. Intravascular lithotripsy has the strongest randomized evidence for heavily calcified lesions, reducing flow-limiting dissection and bailout stenting. Paclitaxel-coated balloons remain a central leave-nothing-behind therapy, with contemporary evidence not confirming the previously proposed late mortality signal. Sirolimus-coated balloons have now entered the field with randomized noninferiority data versus paclitaxel through 2 years. Drug-eluting and other contemporary stents remain important when recoil, dissection, or complex anatomy make a purely scaffold-free strategy unreliable. Conclusions: Contemporary femoropopliteal intervention is best approached as a sequence of lesion characterization, selective preparation, antiproliferative therapy, and selective scaffolding. Treatment should be matched to lesion morphology and the final mechanical result, with focal repair or stenting when dissection or recoil compromises flow.<\/jats:p>","DOI":"10.3390\/jcm15197651","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:21:49Z","timestamp":1790940109000},"page":"7651","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contemporary Endovascular Treatment of Femoropopliteal Disease: Lesion Preparation, Antiproliferative Therapies, and Emerging Technologies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-2498","authenticated-orcid":false,"given":"Mar\u00eda Lourdes del","family":"R\u00edo Sol\u00e1","sequence":"first","affiliation":[{"name":"Servicio de Angiolog\u00eda y Cirug\u00eda Vascular, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"},{"name":"Departamento de Cirug\u00eda, Facultad de Medicina, Universidad de Valladolid, 47005 Valladolid, Spain"},{"name":"Departamento de Ciencias de la Salud, Universidad Europea Miguel de Cervantes, 47012 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-4742","authenticated-orcid":false,"given":"Sandra P\u00e9rez","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Angiolog\u00eda y Cirug\u00eda Vascular, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Asensio Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Servicio de Angiolog\u00eda y Cirug\u00eda Vascular, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jcin.2024.11.038","article-title":"Global algorithm for the endovascular treatment of chronic femoropopliteal lesions: An interdisciplinary expert opinion statement","volume":"18","author":"Korosoglou","year":"2025","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_2","first-page":"243","article-title":"Femoropopliteal interventions for peripheral artery disease: A review of current evidence and future directions","volume":"14","author":"Johnson","year":"2025","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e014024","DOI":"10.1161\/CIRCINTERVENTIONS.124.014024","article-title":"Femoropopliteal endovascular intervention: A review of the current landscape","volume":"18","author":"Tannu","year":"2025","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: Twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107993","DOI":"10.1016\/j.jvir.2026.107993","article-title":"Consensus-driven vessel preparation and definitive endovascular treatment strategies for femoropopliteal arterial lesions based on plaque morphology","volume":"37","author":"Kum","year":"2026","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejvs.2024.08.002","article-title":"Systematic review and network meta-analysis of vessel preparation techniques with plain balloon angioplasty, atherectomy, or intravascular lithotripsy before application of a drug coated balloon to treat atherosclerotic femoropopliteal disease","volume":"69","author":"Yiu","year":"2025","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00270-026-04527-y","article-title":"Paving the way: A systematic review and meta-analysis of randomized controlled trials of atherectomy as vessel preparation prior to balloon angioplasty in peripheral arterial disease","volume":"49","author":"Ho","year":"2026","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1177\/15266028231215354","article-title":"Efficacy and safety of atherectomy combined with balloon angioplasty vs balloon angioplasty alone in patients with femoro-popliteal lesions: A systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Pan","year":"2025","journal-title":"J. Endovasc. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cao, S.B., Yang, Y., Wu, X.L., Chen, Z.G., He, T., and Wang, J.Y. (2026). Drug-coated balloon alone versus atherectomy plus drug-coated balloon for treatment of femoropopliteal atherosclerotic disease: A meta-analysis. J. Cardiothorac. Surg., Epub ahead of printing.","DOI":"10.1186\/s13019-026-04481-3"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.avsg.2026.07.043","article-title":"Clinical efficacy of different endovascular approaches in femoropopliteal artery disease with moderate-to-severe calcification: A meta-analysis","volume":"133","author":"Wang","year":"2026","journal-title":"Ann. Vasc. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e48691","DOI":"10.1097\/MD.0000000000048691","article-title":"Outcomes of intravascular lithotripsy for calcified femoropopliteal and infrapopliteal artery disease: A systematic review with qualitative synthesis","volume":"105","author":"Kofiah","year":"2026","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized Disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcin.2022.01.001","article-title":"The impact of intravascular ultrasound on femoropopliteal artery endovascular interventions: A randomized controlled trial","volume":"15","author":"Allan","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_17","first-page":"949","article-title":"A systematic review on the use of intravascular ultrasound and optical coherence tomography during femoropopliteal endovascular intervention","volume":"106","author":"Rutten","year":"2025","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ejvs.2025.07.023","article-title":"Editor\u2019s Choice\u2014Intravascular ultrasound guided endovascular therapy for femoropopliteal disease: A systematic review and meta-analysis","volume":"70","author":"Ha","year":"2025","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103881","DOI":"10.1016\/j.eclinm.2026.103881","article-title":"Safety of paclitaxel-coated devices in patients with peripheral artery disease: An updated systematic review and meta-analysis of randomized controlled trials","volume":"94","author":"Li","year":"2026","journal-title":"eClinicalMedicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.avsg.2023.11.024","article-title":"Robustness of longitudinal safety and efficacy after paclitaxel-based endovascular therapy for treatment of femoro-popliteal artery occlusive disease: An updated systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Mastrorilli","year":"2024","journal-title":"Ann. Vasc. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jacc.2025.12.017","article-title":"Comparison of sirolimus- vs paclitaxel-coated balloon angioplasty for femoropopliteal artery disease: The SIRONA randomized noninferiority trial","volume":"88","author":"Ingwersen","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jcin.2026.06.021","article-title":"2-year patient-centered and clinical outcomes of sirolimus- versus paclitaxel-coated balloon angioplasty in femoropopliteal artery disease","volume":"19","author":"Ingwersen","year":"2026","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Taneva, G.T., and Mu\u00f1oz Castellanos, J. (2026). Emerging sirolimus-based drug-coated technologies for femoropopliteal disease: A systematic review. J. Endovasc. Ther.","DOI":"10.1177\/15266028261423157"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Xhepa, G., Inzerillo, A., Constantinescu, I., Faerber, P., Gleyzolle, A., Biondetti, P., Del Grande, F., Xhepa, E., Mortellaro, S., and Carrafiello, G. (2025). Limus devices for the treatment of SFA: Latest outcomes and future perspectives. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103594"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/15266028251328156","article-title":"Short- and mid-term efficacy and safety of novel sirolimus-coated balloon for treatment of femoropopliteal lesions: A single-arm meta-analysis","volume":"33","author":"Kalaij","year":"2026","journal-title":"J. Endovasc. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/15266028231202709","article-title":"Systematic review and meta-analysis of clinical outcomes after endovascular treatment in patients with femoropopliteal lesions greater than 50 mm","volume":"32","author":"Fels","year":"2025","journal-title":"J. Endovasc. Ther."},{"key":"ref_27","first-page":"104158","article-title":"Long femoropopliteal lesions challenge the limits of endovascular technique: Contemporary systematic review and meta-analysis","volume":"5","author":"Sayfo","year":"2026","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"131977","DOI":"10.1016\/j.ijcard.2024.131977","article-title":"Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials","volume":"404","author":"Zhou","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_29","first-page":"102432","article-title":"Comparison of endovascular interventions for the treatment of superficial femoral artery disease: A network meta-analysis","volume":"4","author":"Schwartz","year":"2025","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jvs.2025.09.063","article-title":"Network meta-analysis of endovascular treatments for lower extremity arterial disease stratified by lesion location and severity","volume":"83","author":"Zhou","year":"2026","journal-title":"J. Vasc. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1526602817708796","article-title":"Intravascular Ultrasound Validation of Contemporary Angiographic Scores Evaluating the Severity of Calcification in Peripheral Arteries","volume":"24","author":"Yin","year":"2017","journal-title":"J. Endovasc. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and Treatment of Patients with Lower Extremity Peripheral Artery Disease: Consensus Definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e250152","DOI":"10.57264\/cer-2025-0152","article-title":"Performance of stenting in femoropopliteal disease: A systematic literature review and meta-analysis of proportions","volume":"15","author":"Distler","year":"2026","journal-title":"J. Comp. Eff. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.avsg.2025.04.110","article-title":"Contemporary femoropopliteal stents: Reporting gaps of randomized trials","volume":"118","author":"Giannopoulos","year":"2025","journal-title":"Ann. Vasc. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jvs.2020.01.078","article-title":"Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results","volume":"72","author":"Brodmann","year":"2020","journal-title":"J. Vasc. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.avsg.2023.12.081","article-title":"Comparison of different endovascular treatments of femoropopliteal artery in-stent restenosis: A systematic review and Bayesian network meta-analysis","volume":"104","author":"Wang","year":"2024","journal-title":"Ann. Vasc. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cheng, C., Zhen, Y., Hu, Y., Yang, J., Liu, T., and Zheng, J. (2026). Debulking combined with drug-coated balloon for the treatment of femoropopliteal in-stent restenosis: A systematic review and meta-analysis. J. Vasc. Interv. Radiol., 108904.","DOI":"10.1016\/j.jvir.2026.108904"},{"key":"ref_38","first-page":"CD011319","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","volume":"8","author":"Ma","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e004848","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: Twelve-month results of the DEFINITIVE AR study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1177\/15266028251344877","article-title":"Primary drug-coated balloon versus drug-eluting stent for native atherosclerotic femoropopliteal lesions: An updated systematic review and meta-analysis","volume":"33","author":"Cosacco","year":"2026","journal-title":"J. Endovasc. Ther."},{"key":"ref_41","first-page":"2275","article-title":"Cardiovascular outcomes of drug-coated balloon versus drug-eluting stents for femoropopliteal peripheral arterial disease interventions: A meta-regression analysis","volume":"107","author":"Sattar","year":"2026","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.carrev.2023.12.017","article-title":"Efficacy and safety of drug-eluting stents compared with bare metal stent for femoropopliteal artery lesions","volume":"62","author":"Upadhaya","year":"2024","journal-title":"Cardiovasc. Revasc. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7651\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:26:08Z","timestamp":1790940368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":42,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197651"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197651","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}